Item 2.02.Results of Operations and Financial Condition.

On May 6, 2020, Pacific Biosciences of California, Inc. announced its financial results for its first fiscal quarter ended March 31, 2020. A copy of the press release containing the announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

This information, as well as Exhibit 99.1, is intended to be furnished under Item 2.02 of Form 8-K, "Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.




ITEM 9.01.                                                        FINANCIAL STATEMENTS
                                                                  AND EXHIBITS.

5


(d)          Exhibits.


   99.1        Press Release dated May 6, 2020 titled "Pacific Biosciences of
             California, Inc. Announces First Quarter 2020 Financial Results"
             (furnished and not filed herewith solely pursuant to Item 2.02).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses